In this week’s episode of “The Top Line,” Fierce Pharma’s Zoey Becker sits down with Bobby Sheng, the CEO of Bora Pharmaceuticals, to discuss the concept of “friend-shoring” in drug manufacturing.
"Friend-shoring" involves conducting manufacturing processes in countries considered friendly or allied. Sheng discusses the criteria for deeming a country “friendly” and explores whether this strategy could help address drug supply shortages.
To learn more about the topics in this episode:
- Bora plants its flag in the US with $210M acquisition of generics manufacturer Upsher-Smith
- Emergent, pivoting away from CDMO business, sells Baltimore plant to acquisitive Bora for $30M